Three microcolin A and B analogs have been synthesized. Their biological activity profiles were evaluated against several cell lines, revealing the existence of a structural determinant whose role in mediating the antiproliferative effect of the microcolins has heretofore gone unrecognized. While previously described as potent immunosuppressive natural products, we found that these microcolin analogs possessed no selective cytotoxicity when comparing immune cell versus nonimmune cell proliferation. In addition, the amino-terminus of microcolin A has been modified to incorporate a biotinylated polyethylene glycol linker. The biological activity of this biotinylated microcolin A analog was determined. This affinity reagent was shown to retain limited biological activity and thus can serve as a useful probe for elucidating the mechanism of action of microcolin A.
KeywordsNatural products; Immunosuppressant; Synthesis Pharmacological intervention aimed at suppressing the immune system plays an important role in the management of autoimmune diseases, the prevention of rejection after organ transplantation, and treatment of graft versus host diseases. In recent years, many new immunosuppressive drugs have been discovered and developed for clinical use in organ transplantation. The commonly used immunosuppressive drugs fall into five groups with different mechanisms of action: (a) regulators of gene expression; (b) alkylating agents; (c) inhibitors of de novo purine synthesis; (d) inhibitors of de novo pyrimidine synthesis; and (e) inhibitors of kinases and phosphatases. Despite phenomenal success in this disease area, many of these drugs have troublesome side effects and high toxicity profiles. More effective and specific immunosuppressive therapy is needed to further reduce the high morbidity due to infections, malignancies, and graft loss due to chronic rejection after organ transplantation. Thus, the search for more efficacious and tolerant immunosuppressive drugs is vigorously pursued in both academia and pharmaceutical industry. In our chemical biology program, we are interested in developing natural products as biological probes to identify novel proteins for therapeutic intervention (target validation) and the exploration of cell biology (chemical genetics). 1Microcolins A and B are potent antiproliferative and immunosuppressive natural products discovered by Koehn and co-workers from the Venezuelan blue-green algae Lyngbya majuscule (Scheme 1). 2-4 Microcolins A and B were found to be potent in the human two- Microcolin A has been synthesized by Decicco and Grover 6 as well as by Andrus et al. 7 Koehn et al. 5 prepared several analogs by semisynthetic modification and/or degradation of the natural product. They showed that the C-10 free hydroxy functionality, as opposed to general oxygen functionality, is important for the biological activity. Striking loss of activity occurs upon reduction of the pyrrolenone ring C2-C3 olefin. The EC 50 value for 2,3-dihydromicrocolin A is 10,000-fold less potent than...